frequency int64 1 472k | HCPCS_Cd stringlengths 5 5 | HCPCS_Desc stringlengths 4 256 | rn float64 1 1 |
|---|---|---|---|
1 | L7520 | Repair prosthetic device, labor component, per 15 minutes | 1 |
34 | L8606 | Injectable bulking agent, synthetic implant, urinary tract, 1 ml syringe, includes shipping and necessary supplies | 1 |
7 | L8607 | Injectable bulking agent for vocal cord medialization, 0.1 ml, includes shipping and necessary supplies | 1 |
1 | L8615 | Headset/headpiece for use with cochlear implant device, replacement | 1 |
1 | L8616 | Microphone for use with cochlear implant device, replacement | 1 |
3 | L8618 | Transmitter cable for use with cochlear implant device or auditory osseointegrated device, replacement | 1 |
3 | L8619 | Cochlear implant, external speech processor and controller, integrated system, replacement | 1 |
3 | L8621 | Zinc air battery for use with cochlear implant device and auditory osseointegrated sound processors, replacement, each | 1 |
1 | L8623 | Lithium ion battery for use with cochlear implant device speech processor, other than ear level, replacement, each | 1 |
3 | L8624 | Lithium ion battery for use with cochlear implant or auditory osseointegrated device speech processor, ear level, replacement, each | 1 |
2 | L8625 | External recharging system for battery for use with cochlear implant or auditory osseointegrated device, replacement only, each | 1 |
2 | L8628 | Cochlear implant, external controller component, replacement | 1 |
1 | L8629 | Transmitting coil and cable, integrated, for use with cochlear implant device, replacement | 1 |
1 | L8642 | Hallux implant | 1 |
1 | L8659 | Interphalangeal finger joint replacement, 2 or more pieces, metal (e.g., stainless steel or cobalt chrome), ceramic-like material (e.g., pyrocarbon) for surgical implantation, any size | 1 |
14 | L8679 | Implantable neurostimulator, pulse generator, any type | 1 |
4 | L8681 | Patient programmer (external) for use with implantable programmable neurostimulator pulse generator, replacement only | 1 |
6 | L8683 | Radiofrequency transmitter (external) for use with implantable neurostimulator radiofrequency receiver | 1 |
3 | L8689 | External recharging system for battery (internal) for use with implantable neurostimulator, replacement only | 1 |
2 | L8691 | Auditory osseointegrated device, external sound processor, excludes transducer/actuator, replacement only, each | 1 |
2 | L8694 | Auditory osseointegrated device, transducer/actuator, replacement only, each | 1 |
865 | M0201 | Covid-19 vaccine administration inside a patient's home; reported only once per individual home per date of service when only covid-19 vaccine administration is performed at the patient's home | 1 |
1 | M0220 | Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise | 1 |
221 | M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | 1 |
58 | M0240 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses | 1 |
13 | M0241 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital duri | 1 |
1,262 | M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 1 |
132 | M0244 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital duri | 1 |
164 | M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | 1 |
25 | M0246 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider based to the hospital during the covid 19 public health emergen | 1 |
48 | M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | 1 |
10 | M0248 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency | 1 |
36 | P9016 | Red blood cells, leukocytes reduced, each unit | 1 |
17 | P9020 | Platelet rich plasma, each unit | 1 |
1 | P9021 | Red blood cells, each unit | 1 |
1 | P9037 | Platelets, pheresis, leukocytes reduced, irradiated, each unit | 1 |
4 | P9040 | Red blood cells, leukocytes reduced, irradiated, each unit | 1 |
2 | P9041 | Infusion, albumin (human), 5%, 50 ml | 1 |
1 | P9043 | Infusion, plasma protein fraction (human), 5%, 50 ml | 1 |
1 | P9045 | Infusion, albumin (human), 5%, 250 ml | 1 |
1 | P9046 | Infusion, albumin (human), 25%, 20 ml | 1 |
21 | P9047 | Infusion, albumin (human), 25%, 50 ml | 1 |
2 | P9058 | Red blood cells, leukocytes reduced, cmv-negative, irradiated, each unit | 1 |
11 | P9073 | Platelets, pheresis, pathogen-reduced, each unit | 1 |
1,372 | Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 1 |
1 | Q0220 | Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise | 1 |
24 | Q0239 | Injection, bamlanivimab-xxxx, 700 mg | 1 |
33 | Q0240 | Injection, casirivimab and imdevimab, 600 mg | 1 |
58 | Q0243 | Injection, casirivimab and imdevimab, 2400 mg | 1 |
139 | Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 1 |
29 | Q0245 | Injection, bamlanivimab and etesevimab, 2100 mg | 1 |
12 | Q0247 | Injection, sotrovimab, 500 mg | 1 |
2 | Q0477 | Power module patient cable for use with electric or electric/pneumatic ventricular assist device, replacement only | 1 |
2 | Q0479 | Power module for use with electric or electric/pneumatic ventricular assist device, replacement only | 1 |
3 | Q0481 | Microprocessor control unit for use with electric ventricular assist device, replacement only | 1 |
2 | Q0495 | Battery/power pack charger for use with electric or electric/pneumatic ventricular assist device, replacement only | 1 |
1 | Q0496 | Battery, other than lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only | 1 |
3 | Q0497 | Battery clips for use with electric or electric/pneumatic ventricular assist device, replacement only | 1 |
2 | Q0498 | Holster for use with electric or electric/pneumatic ventricular assist device, replacement only | 1 |
3 | Q0501 | Shower cover for use with electric or electric/pneumatic ventricular assist device, replacement only | 1 |
4 | Q0506 | Battery, lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only | 1 |
11 | Q0508 | Miscellaneous supply or accessory for use with an implanted ventricular assist device | 1 |
7 | Q0509 | Miscellaneous supply or accessory for use with any implanted ventricular assist device for which payment was not made under medicare part a | 1 |
11 | Q3001 | Radioelements for brachytherapy, any type, each | 1 |
1,659 | Q3014 | Telehealth originating site facility fee | 1 |
3 | Q4005 | Cast supplies, long arm cast, adult (11 years +), plaster | 1 |
62 | Q4021 | Cast supplies, short arm splint, adult (11 years +), plaster | 1 |
298 | Q4022 | Cast supplies, short arm splint, adult (11 years +), fiberglass | 1 |
1 | Q4041 | Cast supplies, long leg splint, adult (11 years +), plaster | 1 |
1 | Q4042 | Cast supplies, long leg splint, adult (11 years +), fiberglass | 1 |
71 | Q4046 | Cast supplies, short leg splint, adult (11 years +), fiberglass | 1 |
83 | Q4049 | Finger splint, static | 1 |
9 | Q4110 | Primatrix, per square centimeter | 1 |
7 | Q4117 | Hyalomatrix, per square centimeter | 1 |
13 | Q4121 | Theraskin, per square centimeter | 1 |
4 | Q4124 | Oasis ultra tri-layer wound matrix, per square centimeter | 1 |
1 | Q4127 | Talymed, per square centimeter | 1 |
1 | Q4132 | Grafix core and grafixpl core, per square centimeter | 1 |
18 | Q4133 | Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter | 1 |
1 | Q4137 | Amnioexcel, amnioexcel plus or biodexcel, per square centimeter | 1 |
4 | Q4145 | Epifix, injectable, 1 mg | 1 |
2 | Q4148 | Neox cord 1k, neox cord rt, or clarix cord 1k, per square centimeter | 1 |
1 | Q4151 | Amnioband or guardian, per square centimeter | 1 |
25 | Q4158 | Kerecis omega3, per square centimeter | 1 |
128 | Q4159 | Affinity, per square centimeter | 1 |
8 | Q4160 | Nushield, per square centimeter | 1 |
46 | Q4162 | Woundex flow, bioskin flow, 0.5 cc | 1 |
1 | Q4163 | Woundex, bioskin, per square centimeter | 1 |
32 | Q4169 | Artacent wound, per square centimeter | 1 |
13 | Q4171 | Interfyl, 1 mg | 1 |
37 | Q4173 | Palingen or palingen xplus, per square centimeter | 1 |
18 | Q4174 | Palingen or promatrx, 0.36 mg per 0.25 cc | 1 |
1 | Q4176 | Neopatch or therion, per square centimeter | 1 |
183 | Q4177 | Floweramnioflo, 0.1 cc | 1 |
39 | Q4178 | Floweramniopatch, per square centimeter | 1 |
27 | Q4180 | Revita, per square centimeter | 1 |
10 | Q4185 | Cellesta flowable amnion (25 mg per cc); per 0.5 cc | 1 |
126 | Q4186 | Epifix, per square centimeter | 1 |
10 | Q4187 | Epicord, per square centimeter | 1 |
6 | Q4188 | Amnioarmor, per square centimeter | 1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.